iQure Pharma Inc

iQure Pharma Inc. is a small pharmaceutical company headquartered in Wilmington, Delaware. Employing four people, the company generates an annual revenue of $2.5 million. iQure Pharma is driven by a mission to bridge the gap between groundbreaking academic research and the pharmaceutical industry, connecting innovative discoveries with the potential for real-world therapeutic solutions. The company focuses on identifying promising compounds originating from underutilized academic research sources. iQure Pharma meticulously evaluates out-licensing opportunities with leading pharmaceutical and biotechnology companies, seeking commercially viable targets with significant medical appeal. From this pool of possibilities, the company selects compounds with a strong potential for commercialization, guiding them through preclinical and clinical development stages while ensuring strict adherence to regulatory and quality standards. A core principle guiding iQure Pharma's operations is a patient-centric approach, ensuring that the needs of those who will benefit from the developed therapies remain at the forefront of every decision made. Furthermore, the company is dedicated to securing necessary investments for its projects, partnering with investors to direct funding towards therapies with strong market potential and a clear focus on addressing unmet clinical needs. For inquiries and further information about iQure Pharma Inc. and its innovative therapeutic solutions, please visit their website at iqurepharma.com.